We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$216B
AUM Growth
+$23B
Cap. Flow
+$15.2B
Cap. Flow %
7.01%
Top 10 Hldgs %
16.18%
Holding
8,493
New
749
Increased
3,978
Reduced
2,659
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 7.19%
2 Technology 6.4%
3 Healthcare 6.06%
4 Industrials 4.94%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPACW
8126
DELISTED
Matlin & Partners Acquisition Corporation
MPACW
$0 ﹤0.01%
+337
New +$158
COF.WS
8127
DELISTED
Capital One Financial Corp
COF.WS
-3,638
Closed -$151K
KAACW
8128
DELISTED
Kayne Anderson Acquisition Corp.
KAACW
$0 ﹤0.01%
+200
New +$175
BHACR
8129
DELISTED
Barington/Hilco Acquisition Corp. Rights
BHACR
$0 ﹤0.01%
1,214
SHLD
8130
CALL
DELISTED
Sears Holding Corporation
SHLD
-50,000
Closed -$443K
IMUC.WS
8131
DELISTED
ImmunoCellular Therapeutics Ltd.
IMUC.WS
$0 ﹤0.01%
2,858
-7,604
-73% -$365
CMDT
8132
DELISTED
iShares Commodity Optimized Trust
CMDT
-28
Closed -$1K
BTX.WS
8133
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
$0 ﹤0.01%
2,701
-4,733
-64% -$1.14K
EGLT
8134
DELISTED
Egalet Corporation
EGLT
-4,901
Closed -$12K
SRCLP
8135
DELISTED
Stericycle, Inc
SRCLP
-571
Closed -$39K
ILG
8136
CALL
DELISTED
ILG, Inc Common Stock
ILG
-40,600
Closed -$1.12M
KODK.WS
8137
DELISTED
Eastman Kodak Company
KODK.WS
$0 ﹤0.01%
1,227
+1,105
+906% +$269
TCHF
8138
DELISTED
iShares Edge MSCI Multifactor Technology ETF
TCHF
-1,924
Closed -$66K
BSWN
8139
DELISTED
VelocityShares VIX Tail Risk ETN
BSWN
-300
Closed -$6K
UBM
8140
DELISTED
E-TRACS UBS Bloomberg CMCI Industrial Metals ETN
UBM
$0 ﹤0.01%
10
FCRE
8141
DELISTED
FC Global Realty Incorporated Common Stock
FCRE
-1,114
Closed -$1K
WSKY
8142
DELISTED
Spirited Funds/ETFMG Whiskey & Spirits ETF
WSKY
-185
Closed -$5K
CISN.WS
8143
DELISTED
Cision Ltd. Warrants, each to purchase one Ordinary Share
CISN.WS
$0 ﹤0.01%
+51
New +$122
AHGP
8144
PUT
DELISTED
Alliance Holdings GP
AHGP
-570,000
Closed -$13.5M
LQ
8145
CALL
DELISTED
La Quinta Holdings Inc.
LQ
-21,700
Closed -$321K
MSCC
8146
CALL
DELISTED
Microsemi Corp
MSCC
-99,900
Closed -$4.67M
ACFC
8147
DELISTED
Atlantic Coast Financial Corporation
ACFC
-6,219
Closed -$49K
BBRG
8148
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
-486
Closed -$2K
ONSIZ
8149
DELISTED
Oncobiologics, Inc. Series B Warrant
ONSIZ
$0 ﹤0.01%
750
-3,300
-81% -$217
JJC
8150
DELISTED
iPath Bloomberg Copper Subindex Total Return ETN due October 22, 2037
JJC
-6,753
Closed -$208K

Similar funds

UBS Group's Q3 2017 Portfolio in Review

As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.

  • UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
  • UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
  • UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
  • UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
  • UBS Group opened 749 new positions and closed 707 in Q3 2017.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.